Literature DB >> 12709022

Heavy-chain only antibodies derived from dromedary are secreted and displayed by mouse B cells.

Viet Khong Nguyen1, Xiangang Zou, Marc Lauwereys, Lea Brys, Marianne Brüggemann, Serge Muyldermans.   

Abstract

Whereas functional heavy (H)-chain antibodies devoid of light (L)- chains account for about half of the circulating immunoglobulins in Camelidae, H-chain only antibodies (HCAbs) are not produced in other healthy mammals including rodents and humans. To test the feasibility of expressing single chain antibodies in the mouse, which on account of their small size and antigen-recognition properties would have a major impact on antibody engineering strategies, we constructed a rearranged dromedary H-chain gene encoding the immunoglobulin G2a (IgG2a) isotype with specificity for hen-egg lysozyme (HEL). This IgG2a H-chain gene was introduced into mouse myeloma cells not expressing endogenous immunoglobulin H- or L-chains. Unexpectedly the mouse cells processed and expressed the introduced H-chain as naturally occurring dromedary antibody. For this the first constant (C) region exon was proficiently removed from the recombinant H-chain transcript. This resulted in specific H-chain antibodies of the correct molecular weight (2 x 50 000 MW) secreted as disulfide-linked homodimers and displayed on the mouse cell surface as glycosyl-phosphatidyl-inositol-linked B-cell receptor. The results indicate that antibody expression and maturation without immunoglobulin L-chain is feasible and paves the way for the generation of transgenic single chain antibody repertoires.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709022      PMCID: PMC1782939          DOI: 10.1046/j.1365-2567.2003.01633.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

1.  Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain.

Authors:  Xiangang Zou; Tony A Piper; Jennifer A Smith; Nicholas D Allen; Jian Xian; Marianne Brüggemann
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

2.  A C-terminal signal prevents secretion of luminal ER proteins.

Authors:  S Munro; H R Pelham
Journal:  Cell       Date:  1987-03-13       Impact factor: 41.582

3.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

4.  Immunoglobulin heavy chain binding protein.

Authors:  I G Haas; M Wabl
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

5.  Murine heavy chain disease.

Authors:  S L Morrison
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

6.  Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies.

Authors:  V K Nguyen; R Hamers; L Wyns; S Muyldermans
Journal:  Mol Immunol       Date:  1999-06       Impact factor: 4.407

7.  Heavy-chain antibodies in Camelidae; a case of evolutionary innovation.

Authors:  Viet Khong Nguyen; Chen Su; Serge Muyldermans; Wessel van der Loo
Journal:  Immunogenetics       Date:  2002-02-26       Impact factor: 2.846

8.  Chemical typing of human kappa light chain subgroups expressed by human hybrid myelomas.

Authors:  G Galfrè; C Milstein
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

9.  Reactions of peripheral blood mononuclear cells (PBMC) of camels with monoclonal antibodies against ruminant leukocytes.

Authors:  H Ungar-Waron; R Yagil; J Brenner; R Paz; N Partosh; C Van Creveld; E Lubashevsky; Z Trainin
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2003-03       Impact factor: 2.268

10.  gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model.

Authors:  A Alexander; M Steinmetz; D Barritault; B Frangione; E C Franklin; L Hood; J N Buxbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

View more
  8 in total

Review 1.  Distinct antibody species: structural differences creating therapeutic opportunities.

Authors:  Serge Muyldermans; Vaughn V Smider
Journal:  Curr Opin Immunol       Date:  2016-02-27       Impact factor: 7.486

2.  Generation of heavy-chain-only antibodies in mice.

Authors:  Rick Janssens; Sylvia Dekker; Rudi W Hendriks; George Panayotou; Alexandra van Remoortere; John Kong-a San; Frank Grosveld; Dubravka Drabek
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

Review 3.  Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.

Authors:  Mehdi Arbabi-Ghahroudi
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

4.  IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design.

Authors:  Chloe L Stoyle; Paul E Stephens; David P Humphreys; Sam Heywood; Katharine Cain; Neil J Bulleid
Journal:  Biochem J       Date:  2017-09-07       Impact factor: 3.857

5.  Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook.

Authors:  Mehdi Arbabi-Ghahroudi
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

6.  Crystal Structure and Characterization of Human Heavy-Chain Only Antibodies Reveals a Novel, Stable Dimeric Structure Similar to Monoclonal Antibodies.

Authors:  Carl Mieczkowski; Soheila Bahmanjah; Yao Yu; Jeanne Baker; Gopalan Raghunathan; Daniela Tomazela; Mark Hsieh; Mark McCoy; Corey Strickland; Laurence Fayadat-Dilman
Journal:  Antibodies (Basel)       Date:  2020-11-22

7.  Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice.

Authors:  Xiangang Zou; Michael J Osborn; Daniel J Bolland; Jennifer A Smith; Daniel Corcos; Maureen Hamon; David Oxley; Amanda Hutchings; Geoff Morgan; Fatima Santos; Peter J Kilshaw; Michael J Taussig; Anne E Corcoran; Marianne Brüggemann
Journal:  J Exp Med       Date:  2007-12-17       Impact factor: 14.307

Review 8.  Properties, production, and applications of camelid single-domain antibody fragments.

Authors:  M M Harmsen; H J De Haard
Journal:  Appl Microbiol Biotechnol       Date:  2007-08-18       Impact factor: 4.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.